From  ||| S:0 E:5 ||| IN
singing  ||| S:5 E:13 ||| VBG
to  ||| S:13 E:16 ||| TO
speaking ||| S:16 E:24 ||| VB
:  ||| S:24 E:26 ||| :
facilitating  ||| S:26 E:39 ||| VBG
recovery  ||| S:39 E:48 ||| NN
from  ||| S:48 E:53 ||| IN
nonfluent  ||| S:53 E:63 ||| JJ
aphasia  ||| S:63 E:71 ||| NN
It  ||| S:71 E:74 ||| PRP
has  ||| S:74 E:78 ||| VBZ
been  ||| S:78 E:83 ||| VBN
reported  ||| S:83 E:92 ||| VBN
for  ||| S:92 E:96 ||| IN
more  ||| S:96 E:101 ||| JJR
than  ||| S:101 E:106 ||| IN
100  ||| S:106 E:110 ||| CD
years  ||| S:110 E:116 ||| NNS
that  ||| S:116 E:121 ||| IN
patients  ||| S:121 E:130 ||| NNS
with  ||| S:130 E:135 ||| IN
severe  ||| S:135 E:142 ||| JJ
nonfluent  ||| S:142 E:152 ||| JJ
aphasia  ||| S:152 E:160 ||| NNS
are  ||| S:160 E:164 ||| VBP
better  ||| S:164 E:171 ||| JJR
at  ||| S:171 E:174 ||| IN
singing  ||| S:174 E:182 ||| JJ
lyrics  ||| S:182 E:189 ||| NNS
than  ||| S:189 E:194 ||| IN
they  ||| S:194 E:199 ||| PRP
are  ||| S:199 E:203 ||| VBP
at  ||| S:203 E:206 ||| IN
speaking  ||| S:206 E:215 ||| VBG
the  ||| S:215 E:219 ||| DT
same  ||| S:219 E:224 ||| JJ
words ||| S:224 E:229 ||| NNS
.  ||| S:229 E:231 ||| .
This  ||| S:231 E:236 ||| DT
observation  ||| S:236 E:248 ||| NN
led  ||| S:248 E:252 ||| VBD
to  ||| S:252 E:255 ||| TO
the  ||| S:255 E:259 ||| DT
development  ||| S:259 E:271 ||| NN
of  ||| S:271 E:274 ||| IN
melodic  ||| S:274 E:282 ||| JJ
intonation  ||| S:282 E:293 ||| JJ
therapy  ||| S:293 E:301 ||| NN
( ||| S:301 E:302 ||| -LRB-
MIT ||| S:302 E:305 ||| NNP
) ||| S:305 E:306 ||| -RRB-
.  ||| S:306 E:308 ||| .
However ||| S:308 E:315 ||| RB
,  ||| S:315 E:317 ||| ,
the  ||| S:317 E:321 ||| DT
efficacy  ||| S:321 E:330 ||| NN
of  ||| S:330 E:333 ||| IN
this  ||| S:333 E:338 ||| DT
therapy  ||| S:338 E:346 ||| NN
has  ||| S:346 E:350 ||| VBZ
yet  ||| S:350 E:354 ||| RB
to  ||| S:354 E:357 ||| TO
be  ||| S:357 E:360 ||| VB
substantiated  ||| S:360 E:374 ||| VBN
in  ||| S:374 E:377 ||| IN
a  ||| S:377 E:379 ||| DT
randomized  ||| S:379 E:390 ||| JJ
controlled  ||| S:390 E:401 ||| JJ
trial ||| S:401 E:406 ||| NN
.  ||| S:406 E:408 ||| .
Furthermore ||| S:408 E:419 ||| RB
,  ||| S:419 E:421 ||| ,
its  ||| S:421 E:425 ||| PRP$
underlying  ||| S:425 E:436 ||| JJ
neural  ||| S:436 E:443 ||| JJ
mechanisms  ||| S:443 E:454 ||| NNS
remain  ||| S:454 E:461 ||| VBP
unclear ||| S:461 E:468 ||| JJ
.  ||| S:468 E:470 ||| .
The  ||| S:470 E:474 ||| DT
two  ||| S:474 E:478 ||| CD
unique  ||| S:478 E:485 ||| JJ
components  ||| S:485 E:496 ||| NNS
of  ||| S:496 E:499 ||| IN
MIT  ||| S:499 E:503 ||| NNP
are  ||| S:503 E:507 ||| VBP
the  ||| S:507 E:511 ||| DT
intonation  ||| S:511 E:522 ||| NN
of  ||| S:522 E:525 ||| IN
words  ||| S:525 E:531 ||| NNS
and  ||| S:531 E:535 ||| CC
simple  ||| S:535 E:542 ||| JJ
phrases  ||| S:542 E:550 ||| NNS
using  ||| S:550 E:556 ||| VBG
a  ||| S:556 E:558 ||| DT
melodic  ||| S:558 E:566 ||| JJ
contour  ||| S:566 E:574 ||| NN
that  ||| S:574 E:579 ||| WDT
follows  ||| S:579 E:587 ||| VBZ
the  ||| S:587 E:591 ||| DT
prosody  ||| S:591 E:599 ||| NN
of  ||| S:599 E:602 ||| IN
speech  ||| S:602 E:609 ||| NN
and  ||| S:609 E:613 ||| CC
the  ||| S:613 E:617 ||| DT
rhythmic  ||| S:617 E:626 ||| JJ
tapping  ||| S:626 E:634 ||| NN
of  ||| S:634 E:637 ||| IN
the  ||| S:637 E:641 ||| DT
left  ||| S:641 E:646 ||| JJ
hand  ||| S:646 E:651 ||| NN
that  ||| S:651 E:656 ||| WDT
accompanies  ||| S:656 E:668 ||| VBZ
the  ||| S:668 E:672 ||| DT
production  ||| S:672 E:683 ||| NN
of  ||| S:683 E:686 ||| IN
each  ||| S:686 E:691 ||| DT
syllable  ||| S:691 E:700 ||| NN
and  ||| S:700 E:704 ||| CC
serves  ||| S:704 E:711 ||| VBZ
as  ||| S:711 E:714 ||| IN
a  ||| S:714 E:716 ||| DT
catalyst  ||| S:716 E:725 ||| NN
for  ||| S:725 E:729 ||| IN
fluency ||| S:729 E:736 ||| NN
.  ||| S:736 E:738 ||| .
Research  ||| S:738 E:747 ||| NNP
has  ||| S:747 E:751 ||| VBZ
shown  ||| S:751 E:757 ||| VBN
that  ||| S:757 E:762 ||| IN
both  ||| S:762 E:767 ||| DT
components  ||| S:767 E:778 ||| NNS
are  ||| S:778 E:782 ||| VBP
capable  ||| S:782 E:790 ||| JJ
of  ||| S:790 E:793 ||| IN
engaging  ||| S:793 E:802 ||| VBG
fronto-temporal  ||| S:802 E:818 ||| JJ
regions  ||| S:818 E:826 ||| NNS
in  ||| S:826 E:829 ||| IN
the  ||| S:829 E:833 ||| DT
right  ||| S:833 E:839 ||| JJ
hemisphere ||| S:839 E:849 ||| NN
,  ||| S:849 E:851 ||| ,
thereby  ||| S:851 E:859 ||| RB
making  ||| S:859 E:866 ||| VBG
MIT  ||| S:866 E:870 ||| NNP
particularly  ||| S:870 E:883 ||| RB
well  ||| S:883 E:888 ||| RB
suited  ||| S:888 E:895 ||| VBN
for  ||| S:895 E:899 ||| IN
patients  ||| S:899 E:908 ||| NNS
with  ||| S:908 E:913 ||| IN
large  ||| S:913 E:919 ||| JJ
left  ||| S:919 E:924 ||| JJ
hemisphere  ||| S:924 E:935 ||| NN
lesions  ||| S:935 E:943 ||| NNS
who  ||| S:943 E:947 ||| WP
also  ||| S:947 E:952 ||| RB
suffer  ||| S:952 E:959 ||| VB
from  ||| S:959 E:964 ||| IN
nonfluent  ||| S:964 E:974 ||| JJ
aphasia ||| S:974 E:981 ||| NN
.  ||| S:981 E:983 ||| .
Recovery  ||| S:983 E:992 ||| NN
from  ||| S:992 E:997 ||| IN
aphasia  ||| S:997 E:1005 ||| NNS
can  ||| S:1005 E:1009 ||| MD
happen  ||| S:1009 E:1016 ||| VB
in  ||| S:1016 E:1019 ||| IN
two  ||| S:1019 E:1023 ||| CD
ways ||| S:1023 E:1027 ||| NNS
:  ||| S:1027 E:1029 ||| :
either  ||| S:1029 E:1036 ||| RB
through  ||| S:1036 E:1044 ||| IN
the  ||| S:1044 E:1048 ||| DT
recruitment  ||| S:1048 E:1060 ||| NN
of  ||| S:1060 E:1063 ||| IN
perilesional  ||| S:1063 E:1076 ||| JJ
brain  ||| S:1076 E:1082 ||| NN
regions  ||| S:1082 E:1090 ||| NNS
in  ||| S:1090 E:1093 ||| IN
the  ||| S:1093 E:1097 ||| DT
affected  ||| S:1097 E:1106 ||| JJ
hemisphere ||| S:1106 E:1116 ||| NN
,  ||| S:1116 E:1118 ||| ,
with  ||| S:1118 E:1123 ||| IN
variable  ||| S:1123 E:1132 ||| JJ
recruitment  ||| S:1132 E:1144 ||| NN
of  ||| S:1144 E:1147 ||| IN
right-hemispheric  ||| S:1147 E:1165 ||| JJ
regions  ||| S:1165 E:1173 ||| NNS
if  ||| S:1173 E:1176 ||| IN
the  ||| S:1176 E:1180 ||| DT
lesion  ||| S:1180 E:1187 ||| NN
is  ||| S:1187 E:1190 ||| VBZ
small ||| S:1190 E:1195 ||| JJ
,  ||| S:1195 E:1197 ||| ,
or  ||| S:1197 E:1200 ||| CC
through  ||| S:1200 E:1208 ||| IN
the  ||| S:1208 E:1212 ||| DT
recruitment  ||| S:1212 E:1224 ||| NN
of  ||| S:1224 E:1227 ||| IN
homologous  ||| S:1227 E:1238 ||| JJ
language  ||| S:1238 E:1247 ||| NN
and  ||| S:1247 E:1251 ||| CC
speech-motor  ||| S:1251 E:1264 ||| JJ
regions  ||| S:1264 E:1272 ||| NNS
in  ||| S:1272 E:1275 ||| IN
the  ||| S:1275 E:1279 ||| DT
unaffected  ||| S:1279 E:1290 ||| JJ
hemisphere  ||| S:1290 E:1301 ||| NN
if  ||| S:1301 E:1304 ||| IN
the  ||| S:1304 E:1308 ||| DT
lesion  ||| S:1308 E:1315 ||| NN
of  ||| S:1315 E:1318 ||| IN
the  ||| S:1318 E:1322 ||| DT
affected  ||| S:1322 E:1331 ||| JJ
hemisphere  ||| S:1331 E:1342 ||| NN
is  ||| S:1342 E:1345 ||| VBZ
extensive ||| S:1345 E:1354 ||| JJ
.  ||| S:1354 E:1356 ||| .
Treatment-associated  ||| S:1356 E:1377 ||| JJ
neural  ||| S:1377 E:1384 ||| JJ
changes  ||| S:1384 E:1392 ||| NNS
in  ||| S:1392 E:1395 ||| IN
patients  ||| S:1395 E:1404 ||| NNS
undergoing  ||| S:1404 E:1415 ||| VBG
MIT  ||| S:1415 E:1419 ||| NNP
indicate  ||| S:1419 E:1428 ||| VBP
that  ||| S:1428 E:1433 ||| IN
the  ||| S:1433 E:1437 ||| DT
unique  ||| S:1437 E:1444 ||| JJ
engagement  ||| S:1444 E:1455 ||| NN
of  ||| S:1455 E:1458 ||| IN
right-hemispheric  ||| S:1458 E:1476 ||| JJ
structures  ||| S:1476 E:1487 ||| NNS
( ||| S:1487 E:1488 ||| -LRB-
e.g. ||| S:1488 E:1492 ||| NNP
,  ||| S:1492 E:1494 ||| ,
the  ||| S:1494 E:1498 ||| DT
superior  ||| S:1498 E:1507 ||| JJ
temporal  ||| S:1507 E:1516 ||| JJ
lobe ||| S:1516 E:1520 ||| NN
,  ||| S:1520 E:1522 ||| ,
primary  ||| S:1522 E:1530 ||| JJ
sensorimotor ||| S:1530 E:1542 ||| NN
,  ||| S:1542 E:1544 ||| ,
premotor  ||| S:1544 E:1553 ||| NN
and  ||| S:1553 E:1557 ||| CC
inferior  ||| S:1557 E:1566 ||| JJ
frontal  ||| S:1566 E:1574 ||| JJ
gyrus  ||| S:1574 E:1580 ||| JJ
regions ||| S:1580 E:1587 ||| NNS
)  ||| S:1587 E:1589 ||| -RRB-
and  ||| S:1589 E:1593 ||| CC
changes  ||| S:1593 E:1601 ||| NNS
in  ||| S:1601 E:1604 ||| IN
the  ||| S:1604 E:1608 ||| DT
connections  ||| S:1608 E:1620 ||| NNS
across  ||| S:1620 E:1627 ||| IN
these  ||| S:1627 E:1633 ||| DT
brain  ||| S:1633 E:1639 ||| NN
regions  ||| S:1639 E:1647 ||| NNS
may  ||| S:1647 E:1651 ||| MD
be  ||| S:1651 E:1654 ||| VB
responsible  ||| S:1654 E:1666 ||| JJ
for  ||| S:1666 E:1670 ||| IN
its  ||| S:1670 E:1674 ||| PRP$
therapeutic  ||| S:1674 E:1686 ||| JJ
effect ||| S:1686 E:1692 ||| NN
.  ||| S:1692 E:1694 ||| .
